The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate - A revisit of the role of the hydrophile-lipophile balance (HLB) value

Vaccine

Volumn 23, Issue 20, 2005, Pages 2665-2675

  Yang, Ya Wun ^a   Wei, An Chi ^a   Shen, Shan Shan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cell death; Emulsion adjuvants; HLB; Surfactants

Indexed keywords

ADJUVANT; ANTIBODY; ANTIGEN; EMULSIFYING AGENT; LIPOCORTIN 5; OIL; PROPIDIUM IODIDE; VACCINE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CONDUCTANCE; CONTROLLED STUDY; DISPERSION; DRUG EFFECT; DRUG FORMULATION; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HYDROPHILICITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MALE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STAINING; VISCOSITY;

EID: 15044342762     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.007     Document Type: Article

References (47)

1. J.W. Hadden T-cell adjuvants Int J Immunopharmacol. 16 9 1994 703 710
2. M. Singh, and D.T. O'Hagan Recent advances in vaccine adjuvants Pharm Res. 19 6 2002 715 728
3. A. Podda, and G. Del Giudice MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile Expert Rev Vaccines 2 2 2003 197 203
4. D. Sesardic, and R. Dobbelaer European union regulatory developments for new vaccine adjuvants and delivery systems Vaccine 22 19 2004 2452 2456
5. A.T. Glenny, G.A.H. Buttle, and M.F. Stevens Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum J Pathol Bacteriol 34 1931 267 275
6. C. Buteau, S.N. Markovic, and E. Celis Challenges in the development of effective peptide vaccines for cancer Mayo Clin Proc. 77 4 2002 339 349
7. S. Lofthouse Immunological aspects of controlled antigen delivery Adv Drug Deliv Rev. 54 6 2002 863 870
8. M.J. Alonso, S. Cohen, T.G. Park, R.K. Gupta, G.R. Siber, and R. Langer Determinants of release rate of tetanus vaccine from polyester microspheres Pharm Res. 10 7 1993 945 953
9. M. Chiba, J. Hanes, and R. Langer Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres Biomaterials 18 13 1997 893 901
10. J. Hanes, M. Chiba, and R. Langer Polymer microspheres for vaccine delivery Pharm Biotechnol. 6 1995 389 412
11. I. Jabbal-Gill, W. Lin, O. Kistner, S.S. Davis, and L. Illum Polymeric lamellar substrate particles for intranasal vaccination Adv Drug Deliv Rev. 51 1-3 2001 97 111
12. S. Zhou, X. Liao, X. Li, X. Deng, and H. Li Poly-d,l-lactide-co- poly(ethylene glycol) microspheres as potential vaccine delivery systems J Control Release 86 2-3 2003 195 205
13. R. Hunter, F. Strickland, and F. Kezdy The adjuvant activity of nonionic block polymer surfactants. Part I. The role of hydrophile-lipophile balance J Immunol. 127 3 1981 1244 1250
14. A.C. Allison Squalene and squalane emulsions as adjuvants Methods 19 1 1999 87 93
15. D.B. Flies, and L. Chen A simple and rapid vortex method for preparing antigen/adjuvant emulsions for immunization J Immunol Methods 276 1-2 2003 239 242
16. B.P. Mahon The rational design of vaccine adjuvants for mucosal and neonatal immunization Curr Med Chem. 8 9 2001 1057 1075
17. K. Holmberg, B. Jönsson, B. Kronberg, and B. Lindman Surfactants and polymers in aqueous solution 2nd ed. 2003 Wiley New York
18. C.A. Wu, and Y.W. Yang Induction of cell death by saponin and antigen delivery Pharm Res. 21 2 2004 271 277
19. Y.W. Yang, C.A. Wu, and W.J. Morrow The apoptotic and necrotic effects of tomatine adjuvant Vaccine 22 17-18 2004 2316 2327
20. Y.W. Yang, C.A. Wu, and W.J. Morrow Cell death induced by vaccine adjuvants containing surfactants Vaccine 22 11-12 2004 1524 1536
21. K. Hariharan, and N. Hanna Development and application of PROVAX (TM) adjuvant formulation for subunit cancer vaccines Adv Drug Delivery Rev. 32 3 1998 187 197
22. D.S. McVey, M.M. Chengappa, D.E. Mosier, G.G. Stone, R.D. Oberst, and M.J. Sylte Immunogenicity of chi4127 phoP-Salmonella enterica serovar Typhimurium in dogs Vaccine 20 11-12 2002 1618 1623
23. K. Hariharan, G. Braslawsky, A. Black, S. Raychaudhuri, and N. Hanna The induction of cytotoxic T cells and tumor regression by soluble antigen formulation Cancer Res. 55 16 1995 3486 3489
24. P. Rajananthanan, G.S. Attard, N.A. Sheikh, and W.J. Morrow Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice Vaccine 18 1-2 1999 140 152
25. P. Rajananthanan, G.S. Attard, N.A. Sheikh, and W.J. Morrow Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses Vaccine 17 7-8 1999 715 730
26. S. Raychaudhuri, M. Tonks, F. Carbone, T. Ryskamp, W.J. Morrow, and N. Hanna Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo Proc Natl Acad Sci USA 89 1-7 1992 8308 8312
27. N.A. Sheikh, P. Rajananthanan, G.S. Attard, and W.J. Morrow Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants Vaccine 17 23-24 1999 2974 2982
28. E.E. Karagouni, and L. Hadjipetrou-Kourounakis Regulation of isotype immunoglobulin and interleukin production by adjuvants in vitro J Clin Lab Immunol. 33 1 1990 29 39
29. E.E. Karagouni, and L. Hadjipetrou-Kourounakis Regulation of isotype immunoglobulin production by adjuvants in vivo Scand J Immunol. 31 6 1990 745 754
30. I. Jabbal-Gill, W. Lin, P. Jenkins, P. Watts, M. Jimenez, and L. Illum Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines Vaccine 18 3-4 1999 238 250
31. J.M. Kemp, M. Kajihara, S. Nagahara, A. Sano, M. Brandon, and S. Lofthouse Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses Vaccine 20 7-8 2002 1089 1098
32. N. Puri, and P.J. Sinko Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation J Control Release 69 1 2000 69 80
33. N. Puri, J.H. Kou, and P.J. Sinko Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. Part I. In vitro characterization J Control Release 69 1 2000 53 67
34. R.S. Raghuvanshi, Y.K. Katare, K. Lalwani, M.M. Ali, O. Singh, and A.K. Panda Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants Int J Pharm. 245 1-2 2002 109 121
35. B.B. Youan, T.L. Jackson, L. Dickens, C. Hernandez, and G. Owusu-Ababio Protein release profiles and morphology of biodegradable microcapsules containing an oily core J Control Release 76 3 2001 313 326
36. M. Singh, X.M. Li, H. Wang, J.P. McGee, T. Zamb, and W. Koff Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models Vaccine 16 4 1998 346 352
37. R.L. Hunter, and B. Bennett The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers J Immunol 133 6 1984 3167 3175
38. H. Snippe, M.J. De Reuver, F. Strickland, J.M. Willers, and R.L. Hunter Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity Int Arch Allergy Appl Immunol. 65 4 1981 390 398
39. L.F. Woodard, and R.L. Jasman Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants Vaccine 3 2 1985 137 144
40. S. Fukanoki, K. Matsumoto, H. Mori, and R. Takeda Relation between antigen release and immune response of oil adjuvanted vaccines in chickens J Vet Med Sci. 62 6 2000 571 574
41. K. Oda, H. Matsuda, T. Murakami, S. Katayama, T. Ohgitani, and M. Yoshikawa Relationship between adjuvant activity and amphipathic structure of soyasaponins Vaccine 21 17-18 2003 2145 2151
42. H. HogenEsch Mechanisms of stimulation of the immune response by aluminum adjuvants Vaccine 20 Suppl 3 2002 S34 S39
43. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 6671 1998 86 89
44. M.L. Albert, S.F. Pearce, and L.M. Francisco Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 7 1998 1359 1368
45. B. Sauter, M.L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J Exp Med 191 3 2000 423 434
46. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu Rev Immunol. 20 2002 621 667
47. T. Iyoda, S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, and Y. Maeda The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo J Exp Med. 195 10 2002 1289 1302